Cells transfected with a non-neutralizing antibody gene are resistant to HIV infection: Targeting the endoplasmic reticulum and trans-golgi network

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1489-1496

  Zhou, Paul ^a   Goldstein, Simoy ^b   Devadas, Krishnakumar ^a   Tewari, Deepanker ^a   Notkins, Abner Louis ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; GOLGI COMPLEX; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PLASMID; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; ENDOPLASMIC RETICULUM; GENE PRODUCTS, ENV; GIANT CELLS; GOLGI APPARATUS; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; INTRACELLULAR FLUID; JURKAT CELLS; NEUTRALIZATION TESTS; PRECIPITIN TESTS; RATS; TRANSFECTION; VIRUS REPLICATION;

EID: 0031892153     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Rothman, J. E., and F. T. Wieland. 1996. Protein sorting by transport vesicles. Science 272:227.
2. Marasco, W. A., W. A. Haseltine, and S. Y. Chen. 1993. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. USA 90:7889.
3. Mhashikar, A. M., J. Bagley, S. Y. Chen, A. M. Szilvay, D. G. Helland, and W. A. Marasco. 1995. Inhibition of HIV-1 tat-mediated LTR transactivation and HIV-1 infection by anti-tat single chain intrabodies. EMBO J. 14:1542.
4. ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes. Biochem. Biophys. Res. Commun. 197:422.
5. Duan, L., O. Bagasra, M. A. Laughlin, J. W. Oakes, and R. J. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-rev single-chain antibody. Proc. Natl. Acad. Sci. USA 91:5075.
6. Shaheen, F., L. Duan, M. Zhu, O. Bagasra, and R. J. Pomerantz. 1996. Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. J. Virol. 70:3392.
7. Maciejewski, J. P., F. F. Weichold, N. S. Young, A. Cara, D. Zella, M. S. Reitz, Jr., and R. C. Gallo. 1995. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1:667.
8. Richardson, J. H., J. G. Sodroski, T. A. Waldmann, and W. A. Marasco. 1995. Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the a subunit of the receptor. Proc. Natl. Acad. Sci. USA 92:3137.
9. Beerli, R. R., W. Wels, and N. E. Hynes. 1994. Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J. Biol. Chem. 269:23931.
10. Deshane, J., F. Loechel, R. M. Conry, G. P. Siegal, C. R. King, and D. T. Cruiel. 1994. Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 over-expressing cancer cell lines. Gene Ther. 1:332.
11. Dalgleish, A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763.
12. Sodroski, J., W. C. Goh, C. Rosen, K. Campbell, and W. A. Haseltine. 1986. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322:470.
13. Lifson, J. D., M. B. Feinberg, G. R. Reyes, L. Rabin, B. Banapour, S. Chakrabarti, B. Moss, F. Wong-Staal, K. S. Steimer, and E. G. Engleman. 1986. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoproteins. Nature 323:725.
14. Deng, H. K., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. D. Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.
15. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667.
16. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.
17. Feng, Y., C. Broder, P. Kennedy, and E. Berger. 1996. HIV-1 entry cofactor: functional cDN A cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872.
18. Willey, R., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85:9580.
19. Hallenberger, S., M. Moulard, M. Sordel, H.-D. Klenk, and W. Garten. 1997. The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. J. Virol. 71:1036.
20. + T lymphocytes. Proc. Natl. Acad. Sci. USA 93:7695.
21. Allan, J. S., J. E. Coligan, F. Burin, M. F. McLane, J. G. Sodroski, C. A. Rosen, W. A. Haseltine, T. H. Lee, and M. Essex. 1985. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228:1091.
22. Burnstein, H. B., S. P. Tucker, S. R. Kar, S. A. McPherson, D. T. McPherson, J. W. Dubay, J. Lebowitz, R. W. Compans, and E. Hunter. 1995. Oligomerization of the hydrophobic heptad repeat of gp41. J. Virol. 69:2745.
23. Ebenbichler, C. F., H. Stoiber, R. Schneider, J. R. Patsch, and M. P. Dierich. 1996. The human immunodeficiency virus type 1 transmembrane gp41 protein is a calcium-binding protein and interacts with the putative second-receptor molecules in a calcium-dependent manner. J. Virol. 70:1723.
24. Lodge, R., H. Gottlinger, D. Gabuzda, E. A. Cohen, and G. Lemay. 1994. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68:4857.
25. Adamson, D. C., B. Wildemann, M. Sasaki, J. D. Glass, J. C. McArthur, V. I. Christov, T. M. Dawson, and V. L. Dawson. 1996. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274:1917.
26. Chen, S. Y., Y. Khori, J. Bagley, and W. A. Marasco. 1994. Combined intra- and extracellular against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. USA 91:5932.
27. Takeda, S., N. A. Dorfman, M. Robert-Guroff, A. L. Notkins, and R. F. Rando. 1995. Two-phase approach for the expression of high-affinity human anti-human immunodeficiency virus immunoglobulin Fab domain in Escherichia coli. Hybridoma 14:9.
28. Luzio, J. P., B. Brake, G. Banting, K. E. Howell, P. Braghetta, and K. K. Stanley. 1990. Identification, sequencing, and expression of an integral membrane protein of the trans-Golgi network (TGN38). Biochemistry 270:97.
29. Zhou, P., H. Cao, M. Smart, and C. David. 1993. Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteasome gene (LMP-2). Proc. Natl. Acad. Sci. USA 90:2681.
30. Clackson, T., H. R. Hoggenboom, A. D. Griffiths, and G. Winter. 1991. Making antibody fragments using phage display libraries. Nature 352:624.
31. Lee, K. H., F. Matsuda, T. Kinashi, M. Kodaira, and T. Honjo. 1987. A novel family of variable region genes of the human immunoglobulin heavy chain. J. Mol. Biol. 195:761.
32. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat. Med. 3:659.
33. Larder, B. A., G. Darby, and D. D. Richman. 1989. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 241:1731.
34. Lippincott-Schwartz, J., L. C. Yuan, J. S. Bonifacino, and R. D. Klausner. 1989. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56:801.
35. Humphrey, J. S., P. J. Peters, L. C. Yuan, and J. S. Bonifacino. 1993. Localization of TGN38 to the trans-Golgi network: involvement of a cytoplasmic tyrosine-containing sequence. J. Cell Biol. 120:1123 .
36. Bos, K., C. Wraight, and K. K. Stanley. 1993. TGN38 is maintained in the transgolgi network by a tyrosine-containing motif in the cytoplasmic domain. EMBO J. 12:2219.
37. Kelly, R. B. 1985. Pathways of protein secretion in eukaryotes. Science 230:25.
38. Griffiths, G., and K. Simons. 1986. The trans Golgi network: sorting at the exit site of the Golgi complex. Science 234:438.
39. Pfeffer, S. R., and J. E. Rothman. 1987. Biosynthetic protein transport and sorting by the endoplasmic reticulum and Golgi. Annu. Rev. Biochem. 56:829.
40. Tooze, S. A., and W. B. Huttner. 1990. Cell-free protein sorting to the regulated and constitutive secretory pathways. Cell 60:837.
41. Buonocore, L., and J. K. Rose. 1990. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345:625.
42. Pantaleo, G., and A. S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487.
43. Palker, T. J., M. E. Clarck, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bolognesi, and B. F. Haynes. 1988. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85:1932.
44. Burton, D. R. 1997. A vaccine for HIV type 1: the antibody perspective. Proc. Natl. Acad. Sci. USA 94:10018.
45. Earl, P. L., C. C. Broder, R. W. Doms, and B. Moss. 1997. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. J. Virol. 71: 2674.